PhosphoSens CDK1/CycA2 Protein Kinase Assays, Substrates & Recombinant Enzymes

Continuous, real-time assays that directly quantify CDK1/CycA2 catalytic activity — generating a full progress curve in every well for IC₅₀, mechanism, and selectivity studies.

  • Real-time kinetic or TRF endpoint formats
  • Optimized substrates and assay-ready kits
  • Compatible with physiological ATP and cofactors

Designed for: drug discovery, lead optimization, and mechanistic kinase research teams

 

PhosphoSens CDK1/CycA2 kinase assay kit — continuous real-time fluorescence

About CDK1/CycA2

Cyclin-dependent kinase 1 (CDK1) is the founding and most conserved member of the CDK family, functioning as the master regulator of mitotic entry and progression in all eukaryotes. CDK1 requires association with its regulatory partner Cyclin A2 (CCNA2) or Cyclin B1 to achieve catalytic competence; Cyclin A2 drives S-phase and early mitotic functions, while Cyclin B1 governs late mitosis. Activation requires phosphorylation at Thr161 by CDK-activating kinase (CAK) and removal of inhibitory phosphorylations at Thr14 and Tyr15 by the CDC25 phosphatase family. Key substrates include Lamin A/C, nuclear pore complexes, condensins, and the APC/C activator CDC20, coordinating nuclear envelope breakdown, chromosome condensation, and spindle assembly checkpoint satisfaction. CDK1 sits at the convergence of the RB/E2F, DNA-damage checkpoint (ATM/ATR-CHK1/CHK2), and WEE1/MYT1 signaling axes. Dysregulation through Cyclin A2 overexpression, CDK1 amplification, or checkpoint pathway loss is observed across breast, colorectal, hepatocellular, and hematological cancers, making CDK1/CycA2 a compelling oncology drug target.

Why PhosphoSens for CDK1/CycA2?

CDK1/CycA2 presents several assay challenges: the complex is highly active and consumes ATP rapidly, causing endpoint assays such as ADP-Glo and HTRF to underestimate activity or misreport IC50 values when measured at substrate-depletion plateaus. Radiometric filter-binding assays are sensitive but discontinuous, hazardous, and labor-intensive, providing only single time-point snapshots that miss biphasic kinetics. CDK1 is also a frequent off-target for pan-CDK inhibitors, demanding precise selectivity profiling at physiological ATP concentrations. AssayQuant's PhosphoSens CSox-based peptide substrates enable continuous, real-time fluorescence monitoring of CDK1/CycA2 activity, generating full progress curves that faithfully capture initial velocities, covalent inhibitor kinact/KI parameters, and tight-binding compound behavior — all without antibodies or coupled enzymes. Assays run at physiological ATP (1 mM), eliminating Km-ATP bias and enabling direct translation of IC50 to cellular context.

Key Pathways: Cell cycle regulation DNA damage checkpoint signaling APC/C-mediated mitotic exit RB/E2F transcriptional control

Talk to a Scientist

Have questions about CDK1/CycA2 assay design, selectivity panels, or covalent inhibitor characterization?

Ask Our Scientists →
How pricing works:
Select a kit or substrate below, then request a quote. Bundle discounts apply automatically.

Real-Time CDK1/CycA2 Activity Assays

Continuous, real-time fluorescent assays optimized for quantitative CDK1/CycA2 activity measurements, IC50 determination, and mechanistic studies.

Assay Format: Continuous kinetic fluorescence (real-time)

PhosphoSens-Kinetic assays directly quantify enzyme activity by continuously monitoring substrate phosphorylation or dephosphorylation in real time, generating a full progress curve in every well.

Learn more about PhosphoSens-Kinetic →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Kinetic Kinase Activity Kit - AQT0297

Ready-to-use assay kits containing substrate and all essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0297)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $425

Substrate

PhosphoSens Kinase Substrate AQT0297

Bulk PhosphoSens® substrate for assay development and high-throughput workflows.

Specifications

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

Ready to request pricing for CDK1/CycA2?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

TRF CDK1/CycA2 Screening Assays

Robust endpoint TRF assays optimized for high-throughput screening and quantitative CDK1/CycA2 activity measurement in plate-based workflows.

Assay Format: Time-resolved fluorescence (TRF, endpoint)

PhosphoSens-Red assays use europium-based time-resolved fluorescence detection to enable robust, plate-based quantification of enzyme activity, making them well suited for high-throughput screening workflows.

Learn more about PhosphoSens-Red →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Red Kinase Activity Kit - AQT0297

Ready-to-use TRF assay kits containing substrate and essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0297)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer
  • Europium Detection Solution

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $455

Substrate

PhosphoSens Kinase Substrate AQT0297

Bulk substrate for PhosphoSens-Red TRF assays and high-throughput workflows.

Specifications

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

Ready to request pricing for CDK1/CycA2?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

No recombinant enzymes are currently available for CDK1/CycA2.

🔬 150+ peer-reviewed citations · 🏛️ MIT spinout technology · ⚗️ PhosphoSens® validated by independent labs worldwide · Browse technical articles →

Frequently Asked Questions: CDK1/CycA2 Assays

What peptide substrate does AssayQuant recommend for CDK1/CycA2 activity assays?

AssayQuant offers PhosphoSens CSox-labeled peptide substrates derived from validated CDK1 consensus sequences, optimized for CDK1/CycA2 to provide high signal-to-background and linear initial velocity windows. These substrates are provided ready-to-use and have been kinetically characterized for Km and Vmax with the CDK1/CycA2 holoenzyme. Contact our technical team for current catalog substrate recommendations specific to your screening format.

Can PhosphoSens assays distinguish CDK1/CycA2 from CDK2/CycA2 selectivity?

Yes. Because PhosphoSens assays run continuously under identical physiological ATP conditions for both CDK1/CycA2 and CDK2/CycA2, direct side-by-side IC50 comparisons are fully quantitative without ATP-concentration bias that confounds endpoint methods. This enables precise selectivity ratios essential for advancing selective CDK1 chemical probes and avoiding off-target CDK2 liabilities in drug discovery campaigns.

How does the PhosphoSens platform handle covalent CDK1 inhibitor characterization?

PhosphoSens continuous progress curves capture the full time-dependent inhibition profile required to calculate covalent kinact and KI parameters in a single well without the labor of time-point dilution assays. The real-time fluorescence readout resolves the biphasic kinetics of initial noncovalent binding followed by irreversible inactivation, providing mechanistic insight that endpoint assays such as ADP-Glo or HTRF cannot resolve.

Data & Resources

Explore data and documents to support your kinase and phosphatase experiments. Download sample data, protocols and other resources to see how our assays perform and to help you get started in your own lab. All validation data generated using PhosphoSens® assays under recommended conditions.

Still have questions about our products?

Our scientists can help you choose the right assay format, substrate, and enzyme for your experiment.

Stay Informed

Want to hear the latest about our technology? Be among the first to learn about our latest products and services.